Association of vitamin D levels and risk of ovarian cancer: A Mendelian randomization study Journal Article


Authors: Ong, J. S.; Cuellar-Partida, G.; Lu, Y.; Australian Ovarian Cancer Study; Fasching, P. A.; Hein, A.; Burghaus, S.; Beckmann, M. W.; Lambrechts, D.; Van Nieuwenhuysen, E.; Vergote, I.; Vanderstichele, A.; Doherty, J. A.; Rossing, M. A.; Chang-Claude, J.; Eilber, U.; Rudolph, A.; Wang-Gohrke, S.; Goodman, M. T.; Bogdanova, N.; Dörk, T.; Dürst, M.; Hillemanns, P.; Runnebaum, I. B.; Antonenkova, N.; Butzow, R.; Leminen, A.; Nevanlinna, H.; Pelttari, L. M.; Edwards, R. P.; Kelley, J. L.; Modugno, F.; Moysich, K. B.; Ness, R. B.; Cannioto, R.; Høgdall, E.; Høgdall, C. K.; Jensen, A.; Giles, G. G.; Bruinsma, F.; Kjaer, S. K.; Hildebrandt, M. A. T.; Liang, D.; Lu, K. H.; Wu, X. F.; Bisogna, M.; Dao, F.; Levine, D. A.; Cramer, D. W.; Terry, K. L.; Tworoger, S. S.; Stampfer, M.; Missmer, S.; Bjorge, L.; Salvesen, H. B.; Kopperud, R. K.; Bischof, K.; Aben, K. K. H.; Kiemeney, L. A.; Massuger, L. F.; Brooks-Wilson, A.; Olson, S. H.; McGuire, V.; Rothstein, J. H.; Sieh, W.; Whittemore, A. S.; Cook, L. S.; Le, N. D.; Gilks, C. B.; Gronwald, J.; Jakubowska, A.; Lubinski, J.; Kluz, T.; Song, H. L.; Tyrer, J. P.; Wentzensen, N.; Brinton, L.; Trabert, B.; Lissowska, J.; McLaughlin, J. R.; Narod, S. A.; Phelan, C.; Anton-Culver, H.; Ziogas, A.; Eccles, D.; Campbell, I.; Gayther, S. A.; Gentry-Maharaj, A.; Menon, U.; Ramus, S. J.; Wu, A. H.; Dansonka-Mieszkowska, A.; Kupryjanczyk, J.; Timorek, A.; Szafron, L.; Cunningham, J. M.; Fridley, B. L.; Winham, S. J.; Bandera, E. V.; Poole, E. M.; Morgan, T. K.; Risch, H. A.; Goode, E. L.; Schildkraut, J. M.; Pearce, C. L.; Berchuck, A.; Pharoah, P. D. P.; Chenevix-Trench, G.; Gharahkhani, P.; Neale, R. E.; Webb, P. M.; MacGregor, S.
Article Title: Association of vitamin D levels and risk of ovarian cancer: A Mendelian randomization study
Abstract: Background: In vitro and observational epidemiological studies suggest that vitamin D may play a role in cancer prevention. However, the relationship between vitamin D and ovarian cancer is uncertain, with observational studies generating conflicting findings. A potential limitation of observational studies is inadequate control of confounding. To overcome this problem, we used Mendelian randomization (MR) to evaluate the association between single nucleotide polymorphisms (SNPs) associated with circulating 25-hydroxyvitamin D [25(OH)D] concentration and risk of ovarian cancer. Methods: We employed SNPs with well-established associations with 25(OH) D concentration as instrumental variables for MR: rs7944926 (DHCR7), rs12794714 (CYP2R1) and rs2282679 (GC). We included 31 719 women of European ancestry (10 065 cases, 21 654 controls) from the Ovarian Cancer Association Consortium, who were genotyped using customized Illumina Infinium iSelect (iCOGS) arrays. A two-sample (summary data) MR approach was used and analyses were performed separately for all ovarian cancer (10 065 cases) and for high-grade serous ovarian cancer (4121 cases). Results: The odds ratio for epithelial ovarian cancer risk (10 065 cases) estimated by combining the individual SNP associations using inverse variance weighting was 1.27 (95% confidence interval: 1.06 to 1.51) per 20 nmol/L decrease in 25(OH) D concentration. The estimated odds ratio for high-grade serous epithelial ovarian cancer (4121 cases) was 1.54 (1.19, 2.01). Conclusions: Genetically lowered 25-hydroxyvitamin D concentrations were associated with higher ovarian cancer susceptibility in Europeans. These findings suggest that increasing plasma vitamin D levels may reduce risk of ovarian cancer.
Keywords: mortality; protein; genome-wide association; mechanisms; circulating 25-hydroxyvitamin d; d-binding
Journal Title: International Journal of Epidemiology
Volume: 45
Issue: 5
ISSN: 0300-5771
Publisher: Oxford University Press  
Date Published: 2016-10-01
Start Page: 1619
End Page: 1630
Language: English
ACCESSION: WOS:000393184400034
DOI: 10.1093/ije/dyw207
PROVIDER: wos
PMCID: PMC5100621
PUBMED: 27594614
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sara H Olson
    234 Olson
  2. Douglas A Levine
    380 Levine
  3. Fanny Dao
    59 Dao